Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed related topics in the page's sidebar: 'Rheumatoid arthritis' and 'MedlinePlus Genetics'. This is a metadata/navigation change that does not modify the study details or results.
    Difference
    0.0%
    Check dated 2026-03-14T14:09:46.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added related topics: Rheumatoid arthritis and MedlinePlus Genetics. Updated the site revision from v3.4.2 to v3.4.3; core study content remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-07T14:56:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed the 'Rheumatoid arthritis' condition label and the related topic 'MedlinePlus Genetics' from the page.
    Difference
    0.0%
    Check dated 2026-02-20T00:46:39.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-12T18:26:19.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, representing a metadata/version update that does not affect the study information or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T11:16:41.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-29T04:55:35.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.